Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study.

Novak Kujundžić R, Grbeša I, Ivkić M, Krušlin B, Konjevoda P, Gall Trošelj K.

Pathol Oncol Res. 2014 Jul;20(3):687-95. doi: 10.1007/s12253-014-9749-y.

PMID:
24563233
2.

Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.

Li YR, Wu JM, Wang L, Huang X, Shi J, Hu LH.

Acta Otolaryngol. 2005 Apr;125(4):409-14.

PMID:
15823813
3.

Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.

Zhang H, Chen W, Duan CJ, Zhang CF.

World J Surg Oncol. 2013 Jun 18;11:141. doi: 10.1186/1477-7819-11-141.

4.

STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?

Akhtar J, Wang Z, Yu C, Zhang ZP, Bi MM.

Ann Surg Oncol. 2014 Jan;21(1):315-21. doi: 10.1245/s10434-013-3215-z.

PMID:
23975322
5.

Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma.

Mao Y, Zhang DW, Lin H, Xiong L, Liu Y, Li QD, Ma J, Cao Q, Chen RJ, Zhu J, Feng ZQ.

J Exp Clin Cancer Res. 2012 Dec 12;31:101. doi: 10.1186/1756-9966-31-101.

6.

Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.

Han L, Jiang B, Wu H, Zhang S, Lu X.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):6734-42.

7.

Clinical and molecular prognostic factors in operable laryngeal cancer.

Vlachtsis K, Nikolaou A, Markou K, Fountzilas G, Daniilidis I.

Eur Arch Otorhinolaryngol. 2005 Nov;262(11):890-8.

PMID:
15739081
8.

Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.

Foteinou E, Kontos CK, Giotakis AI, Scorilas A.

Biol Chem. 2014 Sep;395(9):1051-62. doi: 10.1515/hsz-2014-0139.

PMID:
24854539
9.

Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.

Okabayashi K, Fujita T, Miyazaki J, Okada T, Iwata T, Hirao N, Noji S, Tsukamoto N, Goshima N, Hasegawa H, Takeuchi H, Ueda M, Kitagawa Y, Kawakami Y.

Cancer Sci. 2012 Sep;103(9):1617-24. doi: 10.1111/j.1349-7006.2012.02355.x.

10.

Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas.

Menéndez ST, Rodrigo JP, Alvarez-Teijeiro S, Villaronga MÁ, Allonca E, Vallina A, Astudillo A, Barros F, Suárez C, García-Pedrero JM.

Mod Pathol. 2012 Aug;25(8):1069-78. doi: 10.1038/modpathol.2012.63.

11.

Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.

White-Al Habeeb NM, Di Meo A, Scorilas A, Rotondo F, Masui O, Seivwright A, Gabril M, Girgis AH, Jewett MA, Yousef GM.

Clin Exp Metastasis. 2015 Aug;32(6):531-41. doi: 10.1007/s10585-015-9725-2.

PMID:
26037892
12.

MicroRNA-519a demonstrates significant tumour suppressive activity in laryngeal squamous cells by targeting anti-carcinoma HuR gene.

Shen Z, Zhan G, Deng H, Ren Y, Ye D, Xiao B, Guo J.

J Laryngol Otol. 2013 Dec;127(12):1194-202. doi: 10.1017/S0022215113003174.

PMID:
24300127
13.

Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.

Dionysopoulos D, Pavlakis K, Kotoula V, Fountzilas E, Markou K, Karasmanis I, Angouridakis N, Nikolaou A, Kalogeras KT, Fountzilas G.

Strahlenther Onkol. 2013 Mar;189(3):202-14. doi: 10.1007/s00066-012-0275-0.

PMID:
23400686
14.

MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma.

Re M, Çeka A, Rubini C, Ferrante L, Zizzi A, Gioacchini FM, Tulli M, Spazzafumo L, Sellari-Franceschini S, Procopio AD, Olivieri F.

Laryngoscope. 2015 Sep;125(9):E306-12. doi: 10.1002/lary.25475.

PMID:
26153151
15.

Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.

Krikelis D, Kotoula V, Bobos M, Fountzilas E, Markou K, Karasmanis I, Angouridakis N, Vlachtsis K, Kalogeras KT, Nikolaou A, Fountzilas G.

Anticancer Res. 2014 Nov;34(11):6495-503.

PMID:
25368251
16.

Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.

Ahmed RA, Shawky Ael-A, Hamed RH.

Pathol Oncol Res. 2014 Jul;20(3):625-33. doi: 10.1007/s12253-014-9741-6.

PMID:
24470282
17.

Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.

Debiais-Delpech C, Godet J, Pedretti N, Bernard FX, Irani J, Cathelineau X, Cussenot O, Fromont G.

Urol Oncol. 2014 May;32(4):426-32. doi: 10.1016/j.urolonc.2013.09.006.

PMID:
24332637
18.

Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.

Fountzilas E, Kotoula V, Angouridakis N, Karasmanis I, Wirtz RM, Eleftheraki AG, Veltrup E, Markou K, Nikolaou A, Pectasides D, Fountzilas G.

PLoS One. 2013 Aug 9;8(8):e70429. doi: 10.1371/journal.pone.0070429.

19.

p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.

Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, Moreno E, Elorriaga J, Alonso I, Baroja A, de la Hoz C.

Laryngoscope. 2003 Jan;113(1):167-72.

PMID:
12514403
20.

Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma.

Fang WK, Gu W, Liao LD, Chen B, Wu ZY, Wu JY, Shen J, Xu LY, Li EM.

Asian Pac J Cancer Prev. 2014;15(2):871-6.

Items per page

Supplemental Content

Support Center